Gainers
- Sensei Biotherapeutics SNSE shares moved upwards by 13.0% to $0.78 during Friday's after-market session. The market value of their outstanding shares is at $20.7 million.
- Qilian Intl Hldg Gr QLI stock rose 10.69% to $0.62. At the close, Qilian Intl Hldg Gr's trading volume reached 108.4K shares. This is 2982.1% of its average volume over the last 100 days. The company's market cap stands at $22.1 million.
- Passage Bio PASG stock moved upwards by 9.74% to $0.72. The company's market cap stands at $39.4 million.
- MiNK Therapeutics INKT stock increased by 9.4% to $1.28. The company's market cap stands at $44.1 million.
- Inovio Pharmaceuticals INO shares increased by 6.32% to $0.42. Trading volume for this security closed at 148.7K, accounting for 4.3% of its average full-day volume over the last 100 days. The company's market cap stands at $112.5 million.
- MultiPlan MPLN stock increased by 6.06% to $1.75. The market value of their outstanding shares is at $1.1 billion.
Losers
- Acurx Pharmaceuticals ACXP shares decreased by 14.6% to $2.8 during Friday's after-market session. At the close, Acurx Pharmaceuticals's trading volume reached 71.1K shares. This is 10.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $36.4 million.
- NexImmune NEXI stock decreased by 13.66% to $2.53. The market value of their outstanding shares is at $2.6 million.
- Sonoma Pharmaceuticals SNOA stock fell 8.56% to $0.17. Sonoma Pharmaceuticals's trading volume hit 541.4K shares by close, accounting for 404.4% of its average volume over the last 100 days. The company's market cap stands at $2.3 million.
- Organovo Holdings ONVO shares fell 8.23% to $1.56. The company's market cap stands at $13.6 million.
- Aclarion ACON shares declined by 8.22% to $0.3. The company's market cap stands at $2.5 million.
- CASI Pharmaceuticals CASI stock decreased by 7.37% to $4.4. The company's market cap stands at $58.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in